1. Liu, Yu, Du, Feiya, Chen, Wei, Lv, Kezhen, Fu, Peifen. 2014. EIF5A2 is a novel chemoresistance gene in breast cancer. In Breast cancer (Tokyo, Japan), 22, 602-7. doi:10.1007/s12282-014-0526-2. https://pubmed.ncbi.nlm.nih.gov/24638963/
2. Liu, Yuwei, Peng, Li, Chen, Jing, Ye, Xujun, Jin, Yalei. 2023. EIF5A2 specifically regulates the transcription of aging-related genes in human neuroblastoma cells. In BMC geriatrics, 23, 83. doi:10.1186/s12877-023-03793-6. https://pubmed.ncbi.nlm.nih.gov/36750933/
3. Li, Yan, Fu, Li, Li, Jian-Biao, Huang, Peng, Guan, Xin-Yuan. 2014. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. In Gastroenterology, 146, 1701-13.e9. doi:10.1053/j.gastro.2014.02.029. https://pubmed.ncbi.nlm.nih.gov/24561231/
4. Francis, Jeffrey C, Capper, Amy, Rust, Alistair G, Pettitt, Stephen J, Swain, Amanda. 2024. Identification of genes that promote PI3K pathway activation and prostate tumour formation. In Oncogene, 43, 1824-1835. doi:10.1038/s41388-024-03028-x. https://pubmed.ncbi.nlm.nih.gov/38654106/
5. Wang, Kun, Wang, Yiyang, Wang, Yuanjian, Zhang, Tianli, Yang, Xingsheng. 2021. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis. In Stem cell research & therapy, 12, 186. doi:10.1186/s13287-021-02256-2. https://pubmed.ncbi.nlm.nih.gov/33726845/
智鼠故事 
